These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12535699)

  • 1. Regional differences in PACAP transport across the blood-brain barrier in mice: a possible influence of strain, amyloid beta protein, and age.
    Nonaka N; Banks WA; Mizushima H; Shioda S; Morley JE
    Peptides; 2002 Dec; 23(12):2197-202. PubMed ID: 12535699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional transport of TNF-alpha across the blood-brain barrier in young ICR and young and aged SAMP8 mice.
    Banks WA; Moinuddin A; Morley JE
    Neurobiol Aging; 2001; 22(4):671-6. PubMed ID: 11445267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional variations in the transport of interleukin-1alpha across the blood-brain barrier in ICR and aging SAMP8 mice.
    Moinuddin A; Morley JE; Banks WA
    Neuroimmunomodulation; 2000; 8(4):165-70. PubMed ID: 11251390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier.
    Nonaka N; Shioda S; Banks WA
    Exp Neurol; 2005 Jan; 191(1):137-44. PubMed ID: 15589520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase-activating polypeptide: Protective effects in stroke and dementia.
    Nonaka N; Banks WA; Shioda S
    Peptides; 2020 Aug; 130():170332. PubMed ID: 32445876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.
    Banks WA; Farr SA; Morley JE; Wolf KM; Geylis V; Steinitz M
    Exp Neurol; 2007 Aug; 206(2):248-56. PubMed ID: 17582399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins.
    Nonaka N; Farr SA; Nakamachi T; Morley JE; Nakamura M; Shioda S; Banks WA
    Peptides; 2012 Aug; 36(2):168-75. PubMed ID: 22687366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.
    Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE
    J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permeability of the blood-brain barrier to albumin and insulin in the young and aged SAMP8 mouse.
    Banks WA; Farr SA; Morley JE
    J Gerontol A Biol Sci Med Sci; 2000 Dec; 55(12):B601-6. PubMed ID: 11129390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein.
    Banks WA; Farr SA; Butt W; Kumar VB; Franko MW; Morley JE
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1113-21. PubMed ID: 11356936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of spinal cord injury on the permeability of the blood-brain and blood-spinal cord barriers to the neurotropin PACAP.
    Banks WA; Kastin AJ; Arimura A
    Exp Neurol; 1998 May; 151(1):116-23. PubMed ID: 9582259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cardiac arrest on the permeability of the mouse blood-brain and blood-spinal cord barrier to pituitary adenylate cyclase activating polypeptide (PACAP).
    Mizushima H; Banks WA; Dohi K; Shioda S; Matsumoto H; Matsumoto K
    Peptides; 1999 Nov; 20(11):1337-40. PubMed ID: 10612448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral amyloid angiopathy, blood-brain barrier disruption and amyloid accumulation in SAMP8 mice.
    del Valle J; Duran-Vilaregut J; Manich G; Pallàs M; Camins A; Vilaplana J; Pelegrí C
    Neurodegener Dis; 2011; 8(6):421-9. PubMed ID: 21411981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease.
    Banks WA; Terrell B; Farr SA; Robinson SM; Nonaka N; Morley JE
    Peptides; 2002 Dec; 23(12):2223-6. PubMed ID: 12535702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons.
    Banks WA; Uchida D; Arimura A; Somogyvári-Vigh A; Shioda S
    Ann N Y Acad Sci; 1996 Dec; 805():270-7; discussion 277-9. PubMed ID: 8993409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine.
    Amin FM; Schytz HW
    J Headache Pain; 2018 May; 19(1):35. PubMed ID: 29785578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efflux of human and mouse amyloid beta proteins 1-40 and 1-42 from brain: impairment in a mouse model of Alzheimer's disease.
    Banks WA; Robinson SM; Verma S; Morley JE
    Neuroscience; 2003; 121(2):487-92. PubMed ID: 14522007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.
    Poon HF; Joshi G; Sultana R; Farr SA; Banks WA; Morley JE; Calabrese V; Butterfield DA
    Brain Res; 2004 Aug; 1018(1):86-96. PubMed ID: 15262209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain.
    D'Agata V; Cavallaro S; Stivala F; Canonico PL
    Eur J Neurosci; 1996 Feb; 8(2):310-8. PubMed ID: 8714702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity.
    Han P; Tang Z; Yin J; Maalouf M; Beach TG; Reiman EM; Shi J
    Neurobiol Aging; 2014 Sep; 35(9):2064-71. PubMed ID: 24726470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.